{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

Chairman of MSIF's International Medical and Scientific Board accepts new role

Alan Thompson has accepted a position on the US National MS Society (NMSS) Research Programs Advisory Committee.

read more

Montreal08 coming soon!

Montréal08 – Living with MS: Global Perspectives on Current Issues, Tuesday 16 September 2008.

read more

Successful ICF Core Sets for MS conference in Switzerland

The International Classification of Functioning, Disability and Health (ICF) Core Sets for MS Consensus Conference took place from 2-4 May, 2008 at the Valens Rehabilitation Centre.

read more

back to top

Profile of the Month : August 2008

Country: Argentina
Age: 37
Occupation: Social Communication Trainer, publicist, designer
Type of MS: Relapse remitting
Year of diagnosis: 2001

Throughout our lives, with or without MS, we face frustrating situations, disappointments and sadness, but we always find a way to keep going.

Read the full article here:

English Francais Espanol Italiano Deutsch Русский

back to top

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

In this multicentre randomised controlled trial the authors studied the effect of intravenous immunoglobulin in people with relapsing remitting MS. Unfortunately it was not of benefit.

authors: Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K; PRIVIG Study Group; UBC MS/MRI Research Group.

source: Neurology. 2008 Jul 22;71(4):265-71.

read more

A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele

The pathology of MS is complex and genes play a role. The authors have developed a new technique to identify those genes that might contribute to risk.

authors: Goris A, Walton A, Ban M, Dubois B, Compston A, Sawcer S.

source: Tissue Antigens. 2008 Jul 15.

read more

Natural history of multiple sclerosis in a population-based cohort

This study looked to see which factors were important in predicting outcome in MS. They found that having the relapsing remitting form, complete recovery from the first relapse, and younger age of onset predicted better clinical outcome.

authors: Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F; for the LORSEP Group.

source: Eur J Neurol. 2008 Jul 15.

read more

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica

This study compared the differences in exposure to different viruses in people with MS and a related but more severe condition called neuromyelitis optica. They found different antibody responses and concluded that this offered further evidence that the conditions are distinct.

authors: Jarius S, Franciotta D, Bergamaschi R, Rauer S, Wandinger K, Petereit H, Maurer M, Tumani H, Vincent A, Eichhorn P, Brigitte W, Wick M, Voltz R.

source: J Neurol Neurosurg Psychiatry. 2008 Jul 17.

read more

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

In this study the authors looked at people who had one attack suggestive of MS. They found that having a second attack was more common in people who smoked. The importance of the study is that smoking is a modifiable risk factor.

authors: Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, O'Reilly EJ, Munger KL, Deisenhammer F, Ascherio A, Berger T.

source: Mult Scler. 2008 Jul 16.

read more

Prevalence of sleep problems in individuals with multiple sclerosis

In this study the authors investigated the presence of sleep disorders among people with MS, finding them to be more frequent than in the general population.

authors: Bamer AM, Johnson KL, Amtmann D, Kraft GH

source: Mult Scler. 2008 Jul 16.

read more

Smoking worsens the prognosis in multiple sclerosis

In this second paper on smoking and MS the authors found links with a worse clinical course.

authors: Sundström P, Nyström L.

source: Mult Scler. 2008 Jul 16. [Epub ahead of print]

read more

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis

This paper found that loss of brain and cord tissue in people with secondary progressive MS is associated with a more severe clinical course. They suggested that MRI measures of atrophy may therefore be useful in future clinical trials.

authors: Furby J, Hayton T, Anderson V, Altmann D, Brenner R, Chataway J, Hughes RA, Smith KJ, Miller DH, Kapoor R.

source: Mult Scler. 2008 Jul 16.

read more

back to top

New EU air travel regulations for people with disabilities

source: European Platform of MS

The European Disability Forum (EDF) has successfully campaigned to improve the rights of air passengers with disabilities.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.